Skip to main content
SpringerLink
Log in

Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The uptake of 3H-5-HT in synaptosomes from rat brains was investigated. Addition of DA or NA had only a slight or no effect on the uptake. When the uptake into NA and DA neurons was inhibited by the addition of high concentrations of NA and DA, the uptake of 3H-5-HT was unchanged. This was also found after destruction of NA and DA neurons by 6-hydroxydopamine treatment. Furthermore, the uptake of 3H-5-HT was almost equal in different brain parts containing NA and DA in very different amounts. These observations show that the uptake measured with 3H-5-HT is specific for 5-HT neurons.

The present study revealed that citalopram and chlorimipramine inhibited uptake competitively, and in this respect the two drugs were equipotent. Compared with a series of tricyclic thymoleptics, the two drugs were the most potent inhibitors of 5-HT uptake, about 20 to 35 times more active than imipramine and amitriptyline. The metabolites of citalopram were also rather potent. The results obtained in the present study correlate closely with those obtained using inhibition of 14C-5-HT uptake in blood platelets, or using the inhibition of H 75/12-induced 5-HT depletion in rat brain.

When rats were treated orally with citalopram or chlorimipramine, the inhibition of 3H-5-HT uptake in synaptosomes derived from these rats was two times greater after citalopram than after chlorimipramine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Campbell, I. C., Todrick, A.: On the pharmacology and biochemistry of the amine uptake mechanism in human blood platelets. Br. J. Pharmacol. 49, 279–287 (1973)

    Google Scholar 

  • Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine. Eur. J. Pharmacol. 5, 357–366 (1969)

    Google Scholar 

  • Cheng, Y.-C., Prusoff, W. H.: Relationship between the inhibition constant (K i ) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108 (1973)

    Google Scholar 

  • Christensen, A. V., Fjalland, B., Pedersen, V., Danneskiold-Samsøe, P., Svendsen, O.: Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties. Eur. J. Pharmacol. 41, 153–162 (1977)

    Google Scholar 

  • Diem, K.: Documenta Geigy. Scientific Tables, 6th ed., pp 173–178. Basle: J. R. Geigy 1962

    Google Scholar 

  • Fredricson Overø, K.: Preliminary studies of the kinetics of citalopram in man. Eur. J. Clin. Pharmacol. (in press, 1978)

  • Fredricson Overø, K., Svendsen, O.: Hepatotoxicity of citalopram in rats and first-pass metabolism. Arch. Toxicol. [suppl. 1], 177–180 (1978)

    Google Scholar 

  • Glowinski, J., Iversen, L. L.: Regional studies of catecholamines in rat brain. I. The disposition of [3H] norepinephrine. [3H] dopamine and [3H] dopa in various regions of the brain. J. Neurochem. 13, 655–669 (1966)

    Google Scholar 

  • Horn, A. S.: Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues. J. Neurochem. 21, 883–888 (1973)

    Google Scholar 

  • Horn, A. S., Trace, R. C. A. M.: Structure-activity relations for the inhibition of 5-hydroxytryptamine uptake by tricyclic antidepressants into synaptosomes from serotoninergic neurones in rat brain homogenates. Br. J. Pharmacol. 51, 399–403 (1974)

    Google Scholar 

  • Hyttel, J.: Endogenous levels and turnover of catecholamines in mouse brain after repeated administration of haloperidol. Psychopharmacologia (Berl.) 36, 237–241 (1974)

    Google Scholar 

  • Hyttel, J.: Neurochemical characterization of a new potent and selective serotonin uptake inhibitor — Lu 10-171. Psychopharmacology (Berl.). 51, 225–233 (1977a)

    Google Scholar 

  • Hyttel, J.: Effect of a selective 5-HT uptake inhibitor — Lu 10-171-on rat brain 5-HT turnover. Acta Pharmacol. Toxicol. (Kbh.) 40, 439–446 (1977b)

    Google Scholar 

  • Kannengiesser, M. H., Hunt, P., Raynaud, J.-P.: An in vitro model for the study of psychotropic drugs and as a criterion of antidepressant activity. Biochem. Pharmacol. 22, 73–84 (1973)

    Google Scholar 

  • König, J. F. R., Klippel, R. A.: The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: Williams & Wilkins 1963

    Google Scholar 

  • Lingjaerde, O.: Inhibitory effect of two newer antidepressants, Lu 5-003 and Lu 3-010, on serotonin uptake in human blood platelets in vitro. Psychopharmacologia (Berl.) 17, 94–99 (1970)

    Google Scholar 

  • Lingjaerde, O.: Studies on the uptake of serotonin in human blood platelets in vitro. Ph.D. Thesis, Oslo, Universitetsforlaget (1971)

    Google Scholar 

  • Mellström, B., Eksborg, S.: Determination of chlorimipramine and desmethylchlorimipramine in human plasma by ion-pair partition chromatography. J. Chromatogr. 116, 475–479 (1976)

    Google Scholar 

  • Nagy, A.: Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats. J. Pharm. Pharmacol. 29, 104–107 (1977)

    Google Scholar 

  • Roos, S. B., Renyi, A. L.: Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur. J. Pharmacol. 7, 270–277 (1969)

    Google Scholar 

  • Roos, S. B., Renyi, A. L.: Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosomes preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol. Toxicol. (Kbh.) 36, 382–394 (1975)

    Google Scholar 

  • Siegel, S.: Nonparametric statistics for the behavioral sciences, pp. 202–213, 213–223, and 229–238. Tokyo: McGraw-Hill 1956

    Google Scholar 

  • Todrick, A., Tait, A. C.: The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs. The relation between structure and potency. J. Pharm. Pharmacol. 21, 751–762 (1969)

    Google Scholar 

  • Tuomistro, J.: A new modification for studying 5-HT uptake by blood platelets: a re-evaluation of tricyclic antidepressants as uptake inhibitors. J. Pharm. Pharmacol. 26, 92–100 (1974)

    Google Scholar 

  • Wong, D. T., Horng, J. S., Bymaster, F. P., Hauser, K. L., Molloy, B. B.: A selective inhibitor of serotonin uptake: Lilly 110140 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci. 15, 471–479 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark

    John Hyttel

Authors
  1. John Hyttel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hyttel, J. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60, 13–18 (1978). https://doi.org/10.1007/BF00429172

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00429172

Key words

Search

Navigation